Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Unilateral and Bilateral Resistance Training in Hypertension

5 sierpnia 2026 zaktualizowane przez: Ceyhun Topcuoglu, Hacettepe University

Comparison of the Effects of Unilateral and Bilateral Resistance Training on Heart Rate Variability, Muscle Strength, and Functional Capacity in Individuals With Hypertension: A Randomized Controlled Trial

Hypertension is associated with autonomic nervous system dysfunction, reduced muscle strength, and impaired functional capacity, all of which contribute to increased cardiovascular risk and decreased quality of life. Resistance training is recommended as a non-pharmacological intervention for hypertension; however, it remains unclear whether unilateral and bilateral resistance training produce different physiological adaptations, particularly regarding cardiac autonomic function.

This randomized controlled trial aims to compare the effects of unilateral and bilateral resistance training on heart rate variability (HRV), muscle strength, and functional capacity in adults with hypertension. Eligible participants aged 40-75 years with a confirmed diagnosis of hypertension will be randomly allocated to one of three groups: a unilateral resistance training group, a bilateral resistance training group, or a control group. Randomization will be performed using a computer-generated block randomization procedure with sex stratification to ensure balanced group allocation.

Participants in the two intervention groups will complete a supervised 12-week resistance training program, performed twice weekly at an intensity of 60-70% of one-repetition maximum (1RM). The unilateral training group will perform exercises using one limb at a time, whereas the bilateral training group will perform the same exercises simultaneously with both limbs. The control group will receive no structured exercise intervention during the study period but will receive general information regarding the benefits of physical activity.

Assessments will be conducted at baseline and after the 12-week intervention. The primary outcome will be heart rate variability measured using a Polar H10 heart rate sensor and Elite HRV software. Secondary outcomes will include peripheral muscle strength assessed by one-repetition maximum testing, functional capacity assessed using the Six-Minute Walk Test and the Glittre Activities of Daily Living Test, and blood pressure measured using a sphygmomanometer.

The findings of this study are expected to provide evidence regarding the optimal resistance training strategy for improving autonomic function and physical performance in individuals with hypertension, thereby supporting the development of safer and more individualized exercise prescriptions.

Przegląd badań

Szczegółowy opis

Hypertension is one of the leading modifiable risk factors for cardiovascular disease and is strongly associated with autonomic nervous system dysfunction. Increased sympathetic activity and reduced parasympathetic activity contribute to impaired cardiovascular regulation, which can be assessed non-invasively through heart rate variability (HRV). Reduced HRV has been associated with increased cardiovascular morbidity and mortality. In addition to autonomic dysfunction, individuals with hypertension frequently exhibit reduced muscle strength, impaired functional capacity, and limitations in daily physical activities.

Resistance training is widely recommended as a safe and effective non-pharmacological intervention for hypertension because it improves blood pressure control, muscular fitness, and overall physical function. Although both unilateral and bilateral resistance training are commonly prescribed, their physiological effects may differ. Unilateral resistance exercises generally involve a smaller active muscle mass, potentially resulting in lower cardiovascular stress while maintaining local muscular adaptations. In contrast, bilateral resistance exercises recruit a larger muscle mass and may induce greater cardiovascular and hemodynamic responses. Despite these theoretical differences, evidence directly comparing their effects on cardiac autonomic regulation in individuals with hypertension remains limited.

The primary objective of this randomized controlled trial is to compare the effects of unilateral and bilateral resistance training on cardiac autonomic function assessed by HRV in adults with hypertension. Secondary objectives include evaluating changes in peripheral muscle strength, functional capacity, activities of daily living, and blood pressure following a supervised resistance training program.

Adults aged 40 to 75 years with a physician-confirmed diagnosis of hypertension who are able to participate safely in resistance exercise will be recruited from Munzur University and Tunceli State Hospital. After providing written informed consent, eligible participants will be randomly assigned to one of three groups using a computer-generated block randomization procedure with sex stratification:

Unilateral Resistance Training Group Bilateral Resistance Training Group Control Group

Participants allocated to the intervention groups will complete a supervised 12-week resistance training program performed twice weekly. Exercise intensity will be prescribed at 60-70% of one-repetition maximum (1RM). Both intervention groups will perform the same resistance exercises, including leg press, knee extension, leg curl, seated row, and chest press. The unilateral group will perform each exercise separately with the right and left limbs, whereas the bilateral group will perform the exercises simultaneously using both limbs. Each exercise session will consist of 2-3 sets of 8-12 repetitions with at least one minute of rest between sets. Training loads will be progressively increased when participants are able to perform more than 20 repetitions with a perceived exertion below 3 on the Modified Borg Scale.

Participants in the control group will not receive supervised resistance training during the 12-week intervention period but will receive standardized education regarding the health benefits of regular physical activity. Following study completion, participants in the control group will be offered the exercise intervention if the training program is demonstrated to be beneficial.

Outcome assessments will be performed at baseline and after completion of the 12-week intervention. HRV will be measured using a Polar H10 heart rate sensor connected to the Elite HRV application. Measurements will be obtained before exercise, immediately after exercise, and during the recovery period. Time-domain variables, including RMSSD, SDNN, pNN50, and mean RR interval, as well as frequency-domain variables, including total power, LF power, HF power, LF/HF ratio, LF peak frequency, and HF peak frequency, will be analyzed.

Peripheral muscle strength will be evaluated using one-repetition maximum testing for leg press, knee extension, leg curl, seated row, and chest press. Functional capacity will be assessed using the Six-Minute Walk Test (6MWT), while functional performance in activities of daily living will be evaluated using the Glittre Activities of Daily Living Test (Glittre-ADL). Resting and exercise blood pressure will be measured using a validated sphygmomanometer.

The study hypothesis is that unilateral resistance training will produce improvements in HRV, muscle strength, and functional capacity comparable to or greater than bilateral resistance training while imposing lower cardiovascular stress. The findings are expected to provide evidence supporting individualized resistance exercise prescription for individuals with hypertension and contribute to the optimization of exercise-based cardiovascular rehabilitation programs.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

54

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Lokalizacje studiów

      • Tunceli, Turcja (Türkiye)
        • Rekrutacyjny
        • Munzur University Faculty of Health Sciences
        • Kontakt:

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Tak

Opis

Inclusion Criteria:

  • Adults aged 40 to 75 years.
  • Physician-confirmed diagnosis of hypertension.
  • Medically stable and able to safely participate in a supervised resistance training program.
  • Able to understand the study procedures and provide written informed consent.

Exclusion Criteria:

  • Presence of cardiovascular diseases other than hypertension.
  • Neurological disorders.
  • Psychiatric disorders.
  • Orthopedic conditions limiting participation in resistance exercise.
  • Any other systemic disease that may interfere with study participation.
  • Cognitive impairment or psychological conditions preventing completion of the assessments.
  • History of recent surgery or medical conditions contraindicating exercise.
  • Inability or unwillingness to comply with the study protocol.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Unilateral Resistance Training Group
Participants will receive a supervised unilateral resistance training program twice weekly for 12 weeks. Training intensity will be set at 60-70% of one-repetition maximum (1RM). Exercises will include leg press, knee extension, leg curl, seated row, and chest press, performed separately with the right and left limbs. Each session will consist of 2-3 sets of 8-12 repetitions with at least 1 minute of rest between sets. Training load will be progressively increased according to participants' performance and perceived exertion.
Participants will complete a supervised unilateral resistance training program twice weekly for 12 weeks. Exercise intensity will be prescribed at 60-70% of one-repetition maximum (1RM). Exercises include leg press, knee extension, leg curl, seated row, and chest press performed separately with the right and left limbs. Each session consists of 2-3 sets of 8-12 repetitions with at least 1 minute of rest between sets. Training loads will be progressively increased based on participants' performance and perceived exertion using the Modified Borg Scale.
Eksperymentalny: Bilateral Resistance Training Group
Participants will receive a supervised bilateral resistance training program twice weekly for 12 weeks. Exercise intensity will be prescribed at 60-70% of one-repetition maximum (1RM). The training program will include leg press, knee extension, leg curl, seated row, and chest press performed simultaneously with both limbs. Each exercise will be completed for 2-3 sets of 8-12 repetitions with at least 1 minute of rest between sets. Training intensity will be progressively increased according to participants' performance and perceived exertion.
Participants will complete a supervised bilateral resistance training program twice weekly for 12 weeks. Exercise intensity will be prescribed at 60-70% of one-repetition maximum (1RM). Exercises include leg press, knee extension, leg curl, seated row, and chest press performed simultaneously with both limbs. Each session consists of 2-3 sets of 8-12 repetitions with at least 1 minute of rest between sets. Training loads will be progressively increased according to participants' performance and perceived exertion using the Modified Borg Scale.
Brak interwencji: Control Group
Participants assigned to the control group will not receive supervised resistance training during the 12-week study period. They will receive standardized education regarding the health benefits of regular physical activity. After study completion, participants will be offered the exercise program if the intervention is shown to be beneficial.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Muscle Strength
Ramy czasowe: Baseline and Week 12
Muscle strength will be assessed using one-repetition maximum (1RM) testing for leg press, knee extension, leg curl, seated row, and chest press exercises.
Baseline and Week 12
Functional Capacity
Ramy czasowe: Baseline and Week 12
Functional capacity will be evaluated using the Six-Minute Walk Test (6MWT). Walking distance and physiological responses will be recorded before and after the intervention.
Baseline and Week 12
RMSSD
Ramy czasowe: Baseline and Week 12
Change in the root mean square of successive differences (RMSSD) measured using heart rate variability analysis. RMSSD is reported in milliseconds (ms). Minimum value: 0 ms. There is no fixed maximum value. Higher values indicate greater parasympathetic activity and improved cardiac autonomic function (better outcome).
Baseline and Week 12
SDNN
Ramy czasowe: Baseline and Week 12
Change in the standard deviation of normal-to-normal intervals (SDNN) measured using heart rate variability analysis. SDNN is reported in milliseconds (ms). Minimum value: 0 ms. There is no fixed maximum value. Higher values indicate greater overall heart rate variability and improved cardiac autonomic function (better outcome).
Baseline and Week 12
pNN50
Ramy czasowe: Baseline and Week 12
Change in the percentage of successive normal-to-normal intervals differing by more than 50 ms (pNN50). The outcome is expressed as a percentage (%). Minimum value: 0%. Maximum value: 100%. Higher values indicate greater parasympathetic activity (better outcome).
Baseline and Week 12
Mean RR Interval
Ramy czasowe: Baseline and Week 12
Change in mean RR interval measured using heart rate variability analysis. The outcome is expressed in milliseconds (ms). Minimum value: 0 ms. There is no fixed maximum value. Higher values generally indicate a lower resting heart rate and improved autonomic regulation (better outcome).
Baseline and Week 12
Total Power
Ramy czasowe: Baseline and Week 12
Change in total power measured using heart rate variability analysis. The outcome is expressed in milliseconds squared (ms²). Minimum value: 0 ms². There is no fixed maximum value. Higher values indicate greater overall heart rate variability (better outcome).
Baseline and Week 12
LF Power
Ramy czasowe: Baseline and Week 12
Change in low-frequency (LF) power measured using heart rate variability analysis. The outcome is expressed in milliseconds squared (ms²). Minimum value: 0 ms². There is no fixed maximum value. Higher values generally indicate greater autonomic modulation.
Baseline and Week 12
HF Power
Ramy czasowe: Baseline and Week 12
Change in high-frequency (HF) power measured using heart rate variability analysis. The outcome is expressed in milliseconds squared (ms²). Minimum value: 0 ms². There is no fixed maximum value. Higher values indicate greater parasympathetic activity (better outcome).
Baseline and Week 12
LF Peak
Ramy czasowe: Baseline and Week 12
Change in low-frequency peak (LF Peak) measured using heart rate variability analysis. The outcome is expressed in hertz (Hz). Minimum value: 0 Hz. There is no fixed maximum value.
Baseline and Week 12
HF Peak
Ramy czasowe: Baseline and Week 12
Change in high-frequency peak (HF Peak) measured using heart rate variability analysis. The outcome is expressed in hertz (Hz). Minimum value: 0 Hz. There is no fixed maximum value.
Baseline and Week 12

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Activities of Daily Living
Ramy czasowe: Baseline and Week 12
Change in activities of daily living performance assessed using the Glittre Activities of Daily Living (Glittre ADL) Test. The outcome is the total time required to complete the Glittre ADL Test, measured in seconds (s). Minimum value: 0 seconds. There is no fixed maximum value. Lower completion times indicate better functional performance in activities of daily living (better outcome), whereas higher completion times indicate poorer functional performance (worse outcome).
Baseline and Week 12
Blood Pressure
Ramy czasowe: Baseline and Week 12
Systolic and diastolic blood pressure will be measured using a validated sphygmomanometer before exercise, immediately after exercise, and 30 minutes after exercise during the baseline and post-intervention assessments.
Baseline and Week 12

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

22 czerwca 2026

Zakończenie podstawowe (Szacowany)

25 września 2026

Ukończenie studiów (Szacowany)

1 października 2026

Daty rejestracji na studia

Pierwszy przesłany

2 sierpnia 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

5 sierpnia 2026

Pierwszy wysłany (Rzeczywisty)

7 sierpnia 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

7 sierpnia 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

5 sierpnia 2026

Ostatnia weryfikacja

1 sierpnia 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • 2026/8-21

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj